Academic Journal
A comparative study on the efficacy of coenzyme Q10 and amitriptyline in the prophylactic treatment of migraine headaches in children: A randomized controlled trial
| العنوان: | A comparative study on the efficacy of coenzyme Q10 and amitriptyline in the prophylactic treatment of migraine headaches in children: A randomized controlled trial |
|---|---|
| المؤلفون: | Omid Yaghini, Neda Hoseini, Mohammad Reza Ghazavi, Vahid Mansouri, Jafar Nasiri, Toktam Moosavian, Mohammad Mehdi Salehi |
| المصدر: | Advanced Biomedical Research, Vol 11, Iss 1, Pp 43-43 (2022) |
| بيانات النشر: | Wolters Kluwer Medknow Publications, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Medicine LCC:Biology (General) |
| مصطلحات موضوعية: | child, clinical trial, co-enzyme q10, migraine disorders, therapy amitriptyline, Medicine, Biology (General), QH301-705.5 |
| الوصف: | Background: Migraine, one of the most common headaches in children, has a significant impact on children and their family's quality of life (QoL). There are two approaches for controlling migraine headaches preventative and controlling acute attacks. Several drugs have been used for this purpose, and tricyclic antidepressants were at the top. Amitriptyline has shown not only a desirable effect on controlling the headaches but also some adverse side effects. Recently, finding effective drugs with fewer side effects, become more critical. Among them, nutraceuticals were one of the promising ones. Materials and Methods: In this randomized clinical trial on 72 patients aged 5–15 years old with diagnosis of migraine based on the International Headache Society criteria, we compare the effectiveness of coenzyme Qten on frequency, duration, and severity of childhood migraine. For comparing the QoL, we used the International PedMIDAS questionnaire. Results: Coenzyme Qten showed good therapeutic effects in children, especially in long-term use; however, amitriptyline showed more rapid response. After 3 months of treatment, clinical outcomes in the two groups did not significantly differ from each other. Similarly, Children's QoL increased in the same way. There are more reported side effects in children using amitriptyline compared to coenzyme Qten. Conclusions: According to results, Co-enzyme Q10, with fewer side effects and comparable therapeutic effects, especially in the long term, could be a good drug for prophylactic treatment of migraine headaches. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2277-9175 |
| Relation: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=43;epage=43;aulast=Yaghini; https://doaj.org/toc/2277-9175 |
| DOI: | 10.4103/abr.abr_235_20 |
| URL الوصول: | https://doaj.org/article/572fdbaf6f4a4904bdc9ef551199aa95 |
| رقم الانضمام: | edsdoj.572fdbaf6f4a4904bdc9ef551199aa95 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 22779175 |
|---|---|
| DOI: | 10.4103/abr.abr_235_20 |